Benefits
Acute Plasma BDNF Signal (Single Small Pilot)
In a single small manufacturer pilot (n=10), a 100 mg dose of whole coffee fruit concentrate was associated with an acute rise in plasma BDNF (brain-derived neurotrophic factor). Plasma BDNF is a difficult marker to interpret because platelet contamination affects readings, and a transient biomarker change has not been linked to any measured cognitive outcome for this ingredient.
Cognitive Performance Support
The main randomized crossover trial (n=72, Robinson 2023) evaluated attention, alertness, and cognitively demanding tasks but found NO benefit versus placebo; the 100 mg dose was associated with increased mental fatigue and reduced sustained-attention accuracy.
Polyphenol-Rich Antioxidant Profile
Coffee fruit pulp delivers a concentrated mix of chlorogenic acids and procyanidins, contributing strong in vitro radical-scavenging activity and adding diversity to dietary polyphenol intake.
Mood and Alertness
The main crossover trial (n=72, Robinson 2023) found NO effect on mood or mental/physical energy versus placebo. Subjective-mood benefits are not established.
Upcycled Coffee Byproduct
Cascara repurposes the coffee fruit pulp historically discarded in bean processing, providing a sustainable polyphenol source alongside conventional coffee consumption.
Mechanism of action
BDNF Modulation
A single small acute pilot reported a transient rise in plasma BDNF after whole coffee fruit concentrate; BDNF is a neurotrophic protein involved in neuronal growth, survival, and synaptic plasticity, but whether a brief peripheral BDNF change reflects any central-nervous-system effect is unestablished for this ingredient.
Chlorogenic Acid Antioxidant Activity
Chlorogenic acid scavenges reactive oxygen species, modulates Nrf2 signaling, and supports endogenous antioxidant enzyme expression in laboratory models.
Procyanidin Vascular Effects
Procyanidins from coffee fruit pulp have been reported to influence endothelial nitric oxide signaling in preclinical models. Any link to vascular or cognitive function in humans is speculative and has not been demonstrated for this extract.
Minimal Direct Caffeine Action
Whole coffee fruit extracts contain only modest caffeine relative to roasted coffee. Investigators have proposed that observed effects are not fully explained by caffeine and may reflect the polyphenol matrix, but this remains a hypothesis from limited acute data.
Clinical trials
Acute, within-subject pilot evaluating plasma BDNF before and after a single 100 mg dose of whole coffee fruit concentrate vs green coffee caffeine, grape seed extract, n-decaffeinated coffee fruit powder, and placebo.
10 healthy adults aged 18-55.
Whole coffee fruit concentrate increased plasma BDNF ~143% from baseline, substantially more than caffeine or grape-seed comparators. This single-acute pilot generated the BDNF marketing narrative; follow-up replication remains modest in scale.
Randomized, double-blind, placebo-controlled crossover trial evaluating 100 mg or 300 mg coffeeberry extract (40% chlorogenic acid) vs 75 mg caffeine vs placebo in healthy adults.
72 healthy adults aged 18-49.
This randomized, double-blind, placebo-controlled crossover trial (n=72) did NOT show cognitive or mood benefit: the published results reported no beneficial effect on mood, mental or physical energy, or cognition, and 100 mg was associated with increased mental fatigue and reduced sustained-attention accuracy versus placebo at 60 minutes, while 300 mg had no effect.
Pilot study registered on ClinicalTrials.gov evaluating whole coffee fruit concentrate (WCFC) and Nutrim combinations on cognitive function, affect, and BDNF in healthy adults.
Healthy adults (pilot phase).
A registered pilot (NCT01965795, ~n=23) whose efficacy results have not been published. Larger confirmatory trials remain the most pressing evidentiary gap.